Digital The growing use of synthetic data in modern pharma The issue isn't whether synthetic data is useful. It is what question we are asking it to answer.
R&D How synthetic data is overcoming privacy challenges in healt... The healthcare industry is saturated in data, but accessing the right data, at the right time, remains a persistent challenge.
R&D Sponsored How synthetic control arms are changing clinical trials Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change. With drawn-out timelines and billions
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.